Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Orthocell Ltd (OCC.AX)

Orthocell Ltd (OCC.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Orthocell Ltd 90 South Street Building 191, Murdoch University Perth WA 6150 AUS

https://www.orthocell.com.au P: +61 893602888 F: +61 893602899

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Orthocell Ltd is a regenerative medicine company. The company is engaged in the development and commercialization of biological medical devices, cell therapies, and related technologies to address unmet clinical needs in human health in the regenerative medicine industry. Its product includes Striate plus; Remplir, which is a collagen wrap used in peripheral nerve repair; and OrthoACI, an implant used for the treatment of articular cartilage defects in the knee and ankle. It also has various other products in its pipeline, such as Tendon Cell Therapy and Collagen Medical Device Platform.

Key Statistics

Overview:

Market Capitalization, $K 217,046
Shares Outstanding, K 271,308
% of Institutional Shareholders 0.72%

Financials:

Annual Sales, $ 7,551 K
Annual Net Income, $ -8,567 K

Growth:

1-Year Return -30.99%
3-Year Return 119.18%
5-Year Return 48.15%
5-Year Revenue Growth 60.03%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm -0.05
Dividend Payout Ratio 0.00%

OCC.AX Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Return-on-Equity % -41.06%
Return-on-Assets % -25.01%
Profit Margin % -113.46%
Debt/Equity 0.03
Price/Sales 18.18
Price/Book 5.27
Book Value/Share 0.15
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar